(BMT CTN 1202) Prospective Multi-Center Cohort for the Evaluation of Biomarkers Predicting Risk of Complications and Mortality Following Allogeneic HCT
Description: 

The goal of this protocol is to establish a cohort of biologic samples collected prospectively from patients treated in BMT CTN centers that will be shared biospecimens resource for conducting future allogenetic HCT correlative studies .

Study Number: 

NCG 234613

Phase: 
I
Principal Investigator: 
ClinicalTrials.Gov ID: 
NCT01879072

To inquire about participating in these studies, call 1-877-ASK-RPCI (1-877-275-7724) or e-mail askrpci@roswellpark.org.